Cell Death and Disease · 2018 · 64 citations · 24 references
MedicineImmunologyOncologyCancer ImmunologyImmunoregulationTumor ImmunologyCancer ImmunotherapyCytokines In Tumor ImmunityGastrointestinal ImmunologyMyeloid-derived Suppressor CellsT Cell Responses To TumorsTumor ImmunopathologyMyeloid-derived Suppressor Cell CytokinesMyeloid-derived Suppressor Cell FunctionMyeloid-derived Suppressor Cell ImmunosuppressionMyeloid-derived Suppressor Cell MarkersMyeloid-derived Suppressor Cell ModulationMyeloid-derived Suppressor Cell PhenotypeMyeloid-derived Suppressor Cell-mediated Suppression
Abstract Myeloid-derived suppressor cells (MDSCs) are a prominent component of the pro-tumoral response. The phenotype of and mechanisms used by MDSCs is heterogeneous and requires more precise characterization in gastric cancer (GC) patients. Here, we have identified a novel subset of CD45 + CD33 low CD11b dim MDSCs in the peripheral blood of GC patients compared to healthy individuals. CD45 + CD33 low CD11b dim MDSCs morphologically resembled neutrophils and expressed high levels of the neutrophil marker CD66b. Circulating CD45 + CD33 low CD11b dim MDSCs effectively suppressed CD8 + T cells activity through the inhibition of CD8 + T cell proliferation and interferon-γ (IFN-γ) and granzyme B (GrB) production. The proportion of CD45 + CD33 low CD11b dim MDSCs also negatively correlated with the proportion of IFN-γ + CD8 + T cell in the peripheral blood of GC patients. GC patient serum-derived IL-6 and IL-8 activated and induced CD45 + CD33 low CD11b dim MDSCs to express arginase I via the PI3K-AKT signaling pathway. This pathway contributed to CD8 + T cell suppression as it was partially rescued by the blockade of the IL-6/IL-8-arginase I axis. Peripheral blood CD45 + CD33 low CD11b dim MDSCs, as well as IL-6, IL-8, and arginase I serum levels, positively correlated with GC progression and negatively correlated with overall patient survival. Altogether, our results highlight that a subset of neutrophilic CD45 + CD33 low CD11b dim MDSCs is functionally immunosuppressive and activated via the IL-6/IL-8-arginase I axis in GC patients.
24
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Je‐In Youn, Srinivas Nagaraj, Michelle Collazo et al. · The Journal of Immunology · 2008 · 1.6K citations · Full text
Life Sciences, Immunology, Oncology +16